Clifford Chance has advised ITM Isotope Technologies Munich SE. ITM Isotope Technologies Munich SE has entered into a loan agreement valued at USD 262.5 million with...
ITM Isotope Technologies Secures US$262.5 Million Financing Agreement
ITM and CNL’s Joint Venture Actineer
Gowling WLG advised ITM on the Joint Venture. ITM Isotope Technologies Munich SE (“ITM”), a leading radiopharmaceutical biotech company, and Canadian Nuclear Laboratories (“CNL”), the manager...
ITM Isotope Technologies Munich’s €255 Million Financing Round
Reed Smith advised ITM, Clifford Chance advised Temasek, and Ashurst advised BlackRock. ITM Isotope Technologies Munich SE announced its latest round of financing from investors Temasek...



























